Protagonist Therapeutics
PTGX
#2251
Rank
NZ$14.48 B
Marketcap
NZ$221.92
Share price
-2.11%
Change (1 day)
45.91%
Change (1 year)

EPS for Protagonist Therapeutics (PTGX)

EPS in 2026 (TTM): NZ$2.20

According to Protagonist Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ$2.23. In 2025 the company made an earnings per share (EPS) of NZ-$3.75 a decrease over its 2024 EPS that were of NZ$8.19.

EPS history for Protagonist Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$2.20-158.58%
2025NZ-$3.75-145.76%
2024NZ$8.19-402.7%
2023NZ-$2.71-43.08%
2022NZ-$4.75-3.7%
2021NZ-$4.9435%
2020NZ-$3.66-33.33%
2019NZ-$5.4874.42%
2018NZ-$3.14-20.74%
2017NZ-$3.97-45.64%
2016NZ-$7.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.47-210.66%๐Ÿ‡บ๐Ÿ‡ธ USA